David Tsay, Decision Scientist, Cardiovascular
David Tsay, M.D. Ph.D. is a decision scientist at Lumleian focusing on cardiovascular diseases and metabolic syndromes. David is a Clinical Cardiology Fellow at Columbia University New York Presbyterian Hospital, where he manages the clinical care of cardiac patients. David has supported multiple Lumleian engagements, primarily for our life-science investor clients, that involve clinical and scientific diligence on cardiovascular therapeutics and devices. David is the primary author of Lumleian’s hyperlipidemia primer. David has worked at Columbia Technology Ventures, where he has extensive experience in the evaluation and development of early-stage healthcare IP. David obtained dual Bachelor of Arts degrees in physics and computer science from Columbia University.